Dominic Hovsepian, Steven Karceski. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Decision MakingFibrinolytic Agents/therapeutic useHumansPhysicians/psychologyStroke/drug therapyTissue Plasminogen Activator/therapeutic use
Substances： See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 2013 PMID： 24062347 DOI： 10.1212/WNL.0b013e3182a94f3c
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910